GH vs. PODD: Guardant Health vs. Insulet Stock Comparison
How do Guardant Health (GH) and Insulet (PODD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Guardant Health (GH) and Insulet (PODD) both fall under the Health Care Equipment & Services industry group, but GH is classified in Health Care Providers & Services while PODD is classified in Health Care Equipment & Supplies.
| Profile Item | GH | PODD |
|---|---|---|
| Name | Guardant Health, Inc. | Insulet Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Services | Health Care Equipment |
| Market Capitalization | 20.41 billion USD | 10.16 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | Nasdaq |
| Listing Date | October 4, 2018 | May 15, 2007 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | GH | PODD |
|---|---|---|
| Total Return (1Y) | 66.53% | -53.25% |
| Total Return (3Y, Annualized) | 92.76% | -0.74% |
| Total Return (5Y, Annualized) | 8.36% | -14.02% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | GH | PODD |
|---|---|---|
| Volatility (1Y, Annualized) | 53.23% | 46.33% |
| Beta (5Y) | 1.69 | 1.04 |
| Max Drawdown (5Y) | -85.09% | -63.02% |
| Avg. Volume (3M) | 1.97M | 1.58M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | GH | PODD |
|---|---|---|
| Sharpe Ratio (1Y) | 1.17 | -1.24 |
| Sortino Ratio (1Y) | 1.84 | -1.51 |
Profitability
ROE (TTM)
Capital efficiency shows on one side only: Insulet (PODD) earns 28.94% on shareholders’ equity, ranked against its industry; Guardant Health (GH) has no ROE this period.
GH
Health Care Equipment & Services industry group
--
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
- GH
- --
PODD
Health Care Equipment & Services industry group
28.94%
- Max
- 47.61%
- PODD
- 28.94%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Guardant Health (GH) reports a negative net margin of -37.93%, usually indicating a net loss over the period. Meanwhile Insulet (PODD) reports 13.44%, ranking against industry peers normally.
GH
Health Care Equipment & Services industry group
-37.93%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
- GH
- -37.93%
PODD
Health Care Equipment & Services industry group
13.44%
- Max
- 29.35%
- PODD
- 13.44%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Guardant Health (GH) reports a negative operating margin of -37.06%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Insulet (PODD) reports 22.54%, ranking against industry peers normally.
GH
Health Care Equipment & Services industry group
-37.06%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
- GH
- -37.06%
PODD
Health Care Equipment & Services industry group
22.54%
- Max
- 35.43%
- PODD
- 22.54%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | GH | PODD |
|---|---|---|
| ROE (TTM) | -- | 28.94% |
| ROA (TTM) | -19.92% | 11.40% |
| Net Margin (TTM) | -37.93% | 13.44% |
| Operating Margin (TTM) | -37.06% | 22.54% |
| Gross Margin (TTM) | 65.19% | 71.88% |
Growth
Revenue Growth
Both Guardant Health (GH) at 32.88% and Insulet (PODD) at 30.73% sit in the top peer quartile for revenue growth, so each is growing its top line faster than typical industry peers.
EPS Growth
Only one side can be read here: Insulet (PODD) reports EPS growth of -39.79%, ranked against its industry; Guardant Health (GH) has no EPS growth figure this period.
Growth Metrics
| Metric | GH | PODD |
|---|---|---|
| Revenue Growth (YoY) | 32.88% | 30.73% |
| Revenue Growth (3Y CAGR) | 29.75% | 27.54% |
| EPS Growth (YoY) | -- | -39.79% |
| EPS Growth (3Y CAGR) | -- | 267.70% |
Financial Strength
Current Ratio (MRQ)
Both Guardant Health (GH) at 3.60 and Insulet (PODD) at 2.51 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
GH
Health Care Equipment & Services industry group
3.60
- Max
- 7.59
- Q3
- 4.00
- GH
- 3.60
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
PODD
Health Care Equipment & Services industry group
2.51
- Max
- 7.59
- Q3
- 4.00
- PODD
- 2.51
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Only one side’s leverage can be read here: Insulet (PODD) carries debt-to-equity ratio of 0.66 against its industry range, while Guardant Health (GH) reports no figure this period.
GH
Health Care Equipment & Services industry group
--
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
- GH
- --
PODD
Health Care Equipment & Services industry group
0.66
- Max
- 1.88
- Q3
- 0.91
- PODD
- 0.66
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | GH | PODD |
|---|---|---|
| Current Ratio (MRQ) | 3.60 | 2.51 |
| Debt / Equity (MRQ) | -- | 0.66 |
| Net Debt / EBITDA | -- | 0.65 |
Dividends
Dividend Yield (TTM)
Neither Guardant Health (GH) nor Insulet (PODD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
GH
Health Care Equipment & Services industry group
0.00%
- GH
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Guardant Health (GH) nor Insulet (PODD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
GH
Health Care Equipment & Services industry group
0.00%
- GH
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | GH | PODD |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: Insulet (PODD) trades at 23.94 times trailing earnings, ranked against its peers, while Guardant Health (GH) has no P/E ratio this period.
GH
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- GH
- --
PODD
Health Care Equipment & Services industry group
23.94
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- PODD
- 23.94
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Insulet (PODD) at 3.19 prices around its industry’s typical P/S ratio, while Guardant Health (GH) at 15.96 clears its benchmark range — GH looks notably rich on sales.
GH
Health Care Equipment & Services industry group
15.96
- GH
- 15.96
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
PODD
Health Care Equipment & Services industry group
3.19
- Max
- 8.80
- Q3
- 4.32
- PODD
- 3.19
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Guardant Health (GH) reports a negative P/B ratio of -73.67, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Insulet (PODD) reports 6.44, ranking against industry peers normally.
GH
Health Care Equipment & Services industry group
-73.67
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
- GH
- -73.67
PODD
Health Care Equipment & Services industry group
6.44
- Max
- 11.68
- PODD
- 6.44
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | GH | PODD |
|---|---|---|
| P/E Ratio (TTM) | -- | 23.94 |
| P/S Ratio (TTM) | 15.96 | 3.19 |
| P/B Ratio (MRQ) | -73.67 | 6.44 |
| Free Cash Flow Yield (TTM) | -0.30% | 1.12% |